Atlas Healthcare Partners, in partnership with Banner Health, one of the largest nonprofit health care systems in the country, announced the acquisition of two ambulatory surgery centers (ASCs) in Scottsdale and Tucson, Arizona. The two ASCs, Banner Surgery Center – Desert Vista and Banner Cardiovascular Center – Tanque Verde, grow Atlas Healthcare’s portfolio to 27 ASCs that it manages throughout the United States.
Banner Surgery Center – Desert Vista, located in Scottsdale, Arizona, will feature two operating rooms. It will also provide pain management and spine services in partnership with two physician investors.
Banner Cardiovascular Center – Tanque Verde was converted from an office-based laboratory (OBL) to an ASC to better serve surgery patients in the Tucson, Arizona area. Arizona EndoVascular has been operating in the center as an OBL performing peripheral arterial disease procedures. The two-room ASC has a mobile c-arm in one operating room and another room is being converted to a cath lab, which will support more complex peripheral arterial disease procedures and allow for diagnostic and therapeutic cardiac and electrophysiology procedures.
Headquartered in Phoenix, Arizona, Atlas Healthcare Partners specializes in the development and management of ASCs in partnership with health systems and physicians. Atlas was formed in 2018 to develop and manage Banner Health’s ASC network in Arizona, Colorado and Wyoming.
In addition to 30 acute-care hospitals, Banner Health also operates an academic medicine division, Banner – University Medicine, as well as Banner MD Anderson Cancer Center, a partnership with one of the world’s leading cancer programs, MD Anderson Cancer Center. Headquartered in Phoenix, Arizona, Banner Health also has locations in California, Colorado, Nebraska, Nevada and Wyoming.
According to the LevinPro HC database, this marks the 25th ambulatory surgery center acquisition of 2022 and the second of the third quarter. The largest acquirer of ASCs this year has been Montecito Medical Real Estate, which has acquired six ASCs since April.
